Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger

September 2009
PLoS Clinical Trials;Sep2009, Vol. 6 Issue 9, Special section p1
Academic Journal
The article focuses on the issue of ghostwriting in medical publishing. It claims that drug companies and medical education and communication companies have built a profitable ghostwriting industry because of the failure of editors, medical schools and universities to address the issue. It cites the move of the World Association of Medical Editors (WAME ) to create a specific policy on ghostwriting. It stresses that authors should produce medical literature that can be believed in.


Related Articles

  • Ghosts still present in the medical machine. Jones, Nicola // Nature;9/17/2009, Vol. 461 Issue 7262, p325 

    The article reports that ghostwriting in medical literature remains, despite the policy changes in drug-company and efforts of journals to cut down the practice in the U.S. It states that the ghostwriting, is a practice that involves pharmaceutical companies designing and paying for studies or...

  • How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised. Matheson, Alastair // PLoS Medicine;Aug2011, Vol. 8 Issue 8, p1 

    The author discusses the International Committee of Medical Journal Editors (ICMJE) guidelines on the authorship of medical journals. He mentions that the most significant feature of the ICMJE guidelines is its distinction between authors and contributors, which is important to address the issue...

  • Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles. Stern, Simon; Lemmens, Trudo // PLoS Medicine;Aug2011, Vol. 8 Issue 8, p1 

    The article focuses on the possible legal remedies to deter the practice of ghostwriting in medical publishing. The authors state that medical ghostwriting can be deterred through the imposition of legal liabilities on guest author's who use their names in ghostwritten articles. They add that...

  • Medical journals and pharmaceutical companies: uneasy bedfellows. Smith, Richard // BMJ: British Medical Journal (International Edition);5/31/2003, Vol. 326 Issue 7400, p1202 

    Focuses on the funding of medical journals by pharmaceutical companies, and questions whether this funding is corrupting the journals. Dependence of free newspapers for physicians and medical journals on income from pharmaceutical advertising; Opinion that drug advertising is often misleading;...

  • GPP2: Good Publication Practices for Sponsored Medical Research: Elevating the Integrity of Scientific Communications. Moser, Marvin; McMurray, Bryce; Sanes-Miller, Carol; Yarker, Yvonne // Medical Roundtable: Cardiovascular Edition;Spring2010, Vol. 1 Issue 2, p120 

    The discussion focused primarily on: (1) organized efforts to elevate the perception of collaborative medical publishing of industry sponsored research, (2) transparency of authorship of medical journal articles, ghost writing and scientific writing assistance, (3) duplicate publication of...

  • 'Nullius in verba'. Richards, Derek // Evidence-Based Dentistry;Sep2010, Vol. 11 Issue 3, p66 

    The author highlights the 350th anniversary celebration by the Royal Society in Great Britain, themed as Nullius in verba, as the Royal Society's motto which serve as standpoint on fair treatment and verification of statements and facts determined in medical research. The author recommends the...

  • Medical publication ghostwriting report gets mixed review.  // Infectious Diseases in Children;Sep2010, Vol. 23 Issue 9, p45 

    The article discloses the findings of a report on medical ghostwriting released by the office of U.S. Senator Charles Grassley on June 24, 2010 in which the National Institutes of Health (NIH), institutions and medical journals play a critical role in ensuring an adequate and meaningful disclosure.

  • Ghostwriting Revisited: New Perspectives but Few Solutions in Sight. V. B.; E. V.; J. C.; S. J.; M. N.; P. S. // PLoS Medicine;Aug2011, Vol. 8 Issue 8, p1 

    An introduction is presented in which the authors discuss various reports within the issue on topics including ghostwriting of medical journals and the authorship of medical literature.

  • Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents. Steinman, Michael A.; Bero, Lisa A.; Mary-Margaret Chren; Landefeld, C. Seth // Annals of Internal Medicine;8/15/2006, Vol. 145 Issue 4, p284 

    Background: Internal documents from the pharmaceutical industry provide a unique window for understanding the structure and methods of pharmaceutical promotion. Such documents have become available through litigation concerning the promotion of gabapentin (Neurontin, Pfizer, Inc., New York, New...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics